Regeneron and ISA Pharmaceuticals Announce Strategic Immuno-Oncology Collaboration

December 17, 2017

Responsive image

TARRYTOWN, N.Y. and LEIDEN, The Netherlands, Dec. 18, 2017 /PRNewswire/ — Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and ISA Pharmaceuticals B.V., a clinical-stage immunotherapy company, today announced a clinical collaboration to advance ISA101, an immunotherapy targeting human…

Category: Precious Metals